Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04556045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 4 more changesShow less
    • Final enrollment: 21 participants (planned 80)
    • Primary completion date changed from estimate of Sep 2026 to May 21, 2026
    • Eligibility criteria expanded, about 26 words
    • Secondary endpoints: details revised at 7 of 10 entries
  2. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised
    v18
  3. Notable Primary completion date: Dec 2025 to Sep 2026v17
  4. Notable Primary completion date: Jun 1, 2025 to Dec 2025
    • Study completion date: Jun 1, 2026 to Dec 2026
    • Eligibility criteria shortened, about 11 words
    • Study description expanded, about 11 words
    v16
  5. Minor Primary completion date: Jan 1, 2025 to Jun 1, 2025
    • Study completion date: Jan 1, 2026 to Jun 1, 2026
    v15
Show 13 earlier versionsHide 13 earlier versions
  1. Minor Eligibility criteria shortened, about 36 wordsv14
  2. Minor Start date changed from estimate of Mar 1, 2024 to Dec 11, 2023v13
  3. Minor Eligibility criteria expanded, about 11 wordsv12
  4. Notable Start date: Sep 1, 2023 to Mar 1, 2024v11
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 1, 2023 to Sep 1, 2023
    • Site details revised
    v10
  6. Minor 2 versions Re-verified since May 1, 2023, no change to tracked fieldsv8-v9
  7. Notable Start date: Feb 1, 2023 to Aug 1, 2023v7
  8. Notable Lead sponsor: Milton S. Hershey Medical Center to Case Comprehensive Cancer Centerv6 Show 8 more changesShow less
    • Primary completion date: Feb 1, 2024 to Jan 1, 2025
    • Start date: Feb 1, 2022 to Feb 1, 2023
    • Study completion date: Feb 1, 2025 to Jan 1, 2026
    • Interventions: Exercise therapy + radiation therapy (Behavioral), Radiation therapy (Radiation) to Exercise therapy (Behavioral)
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints reordered
    • Study description shortened, about 113 words
    • Study site revised
  9. Notable Start date: May 6, 2021 to Feb 1, 2022v5 Show 4 more changesShow less
    • Trial status: Recruiting to Not Yet Recruiting
    • Primary completion date: Mar 1, 2024 to Feb 1, 2024
    • Study completion date: Mar 1, 2024 to Feb 1, 2025
    • Study site revised
  10. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2021 to May 6, 2021
    v4
  11. Notable Start date: Nov 1, 2020 to Mar 1, 2021
    • Primary completion date: Nov 1, 2023 to Mar 1, 2024
    • Study completion date: Nov 1, 2025 to Mar 1, 2024
    v3
  12. Minor Study description shortened, about 7 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of life and physical functioning after completing their radiation therapy. Second, the study is being done to find if the quality of life changes during therapy correlate with measurements of inflammation in the blood. Third, the study is being done to see if adding exercise therapy to radiation therapy will improve survival.
Trial Details
NCT Number NCT04556045
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)
Malignant Neoplasm of Prostate
Related terms Motor Activity, Prostatic Neoplasms
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov